We showed that Th17 cells with a double production of IL-17 and IL-10 were strongly increased in AML patients and that ex vivo patient immune response to an infectious antigen, such as Candida Albicans (C. Albicans), was significantly reduced by Th17. Here, IL10 is linked to acute myeloid leukemia.